Blog

RSS Feed
Posted by Michael Wonder on 03 Jul 2024

Gadopiclenol as an MRI contrast agent: first benefit assessment of a diagnostic agent

1 July 2024 - For the first time, IQWiG has evaluated a drug that is a diagnostic agent within the ...

Read more →